This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/http://heart.bmj.com/content/101/1/10#BIB
Based on the SYMPLICITY studies and CE (Conformité Européenne) certification, renal denervation is c...
The Symplicity studies suggest that intravascular renal sympathetic nervous denervation improves blo...
AbstractCatheter-based renal denervation (RDN) was considered as a promising method for treatment of...
Resistant hypertension continues to pose a major challenge to clinicians worldwide and has serious i...
Improved and durable control of hypertension is a global priority for healthcare providers and polic...
Improved and durable control of hypertension is a global priority for healthcare providers and polic...
Growing evidence demonstrates the suitability of renal denervation in a broad population of patients...
This ESH Position Paper 2021 with updated proposed recommendations was deemed necessary after the pu...
Resistant hypertension is, by definition, a challenge to most physicians treating hypertension. Rena...
Hitesh C Patel,1 Carl Hayward,1 Vassilis Vassiliou,1 Ketna Patel,2 James P Howard,3 Carlo Di Mario11...
The Symplicity HTN-1 and 2 studies proposed renal denervation (RDN) as an effective and safe approac...
Since the publication of the 2018 European Society of Cardiology/European Society of Hypertension (E...
This ESH update was deemed necessary with the publication of new results of sham-controlled randomiz...
This ESH Position Paper 2021 with updated proposed recommendations was deemed necessary after the pu...
AbstractIn the spring of 2012, the Czech Society of Cardiology and Czech Hypertension Society issued...
Based on the SYMPLICITY studies and CE (Conformité Européenne) certification, renal denervation is c...
The Symplicity studies suggest that intravascular renal sympathetic nervous denervation improves blo...
AbstractCatheter-based renal denervation (RDN) was considered as a promising method for treatment of...
Resistant hypertension continues to pose a major challenge to clinicians worldwide and has serious i...
Improved and durable control of hypertension is a global priority for healthcare providers and polic...
Improved and durable control of hypertension is a global priority for healthcare providers and polic...
Growing evidence demonstrates the suitability of renal denervation in a broad population of patients...
This ESH Position Paper 2021 with updated proposed recommendations was deemed necessary after the pu...
Resistant hypertension is, by definition, a challenge to most physicians treating hypertension. Rena...
Hitesh C Patel,1 Carl Hayward,1 Vassilis Vassiliou,1 Ketna Patel,2 James P Howard,3 Carlo Di Mario11...
The Symplicity HTN-1 and 2 studies proposed renal denervation (RDN) as an effective and safe approac...
Since the publication of the 2018 European Society of Cardiology/European Society of Hypertension (E...
This ESH update was deemed necessary with the publication of new results of sham-controlled randomiz...
This ESH Position Paper 2021 with updated proposed recommendations was deemed necessary after the pu...
AbstractIn the spring of 2012, the Czech Society of Cardiology and Czech Hypertension Society issued...
Based on the SYMPLICITY studies and CE (Conformité Européenne) certification, renal denervation is c...
The Symplicity studies suggest that intravascular renal sympathetic nervous denervation improves blo...
AbstractCatheter-based renal denervation (RDN) was considered as a promising method for treatment of...